Content area

|
|

Behandling af tilfældigt fund af gruppe B-streptokokker i urin hos gravide

Forfatter(e)

Martin Høhrmann Hangaard1, Jan Stener Jørgensen1, 2, Hans Jørn Jepsen Kolmos3 & Christina Anne Vinter1, 2

1) Gynækologisk Obstetrisk Afdeling, Odense Universitetshospital, 2) Klinisk institut, Det Sundhedsvidenskabelige Fakultet, Syddansk Universitet, 3) Forskningsenheden for Klinisk Mikrobiologi, Syddansk Universitet og Odense Universitetshospital

Ugeskr Læger 2021;183:V12200968

Reference: 
Ugeskr Læger 2021;183:V12200968
Treatment of incidentally found group B streptococcus in urine of pregnant women

Martin Høhrmann Hangaard, Jan Stener Jørgensen, Hans Jørn Jepsen Kolmos & Christina Anne Vinter

Ugeskr Læger 2021;183:V12200968

Group B streptococcus (GBS) is a group of naturally occurring bacteria that colonises the anogenital region of every third pregnant woman. From the anogenital region they can colonise the urine and cause bacteriuria. It is well documented that treatment of GBS-bacteriuria with more than 104 colony forming units per millilitre (CFU/ml) reduces the risk of maternal and neonatal morbidity. There is, however, no clear evidence as summarised in this review that GBS-bacteriuria more than 104 CFU/ml increases the risk of maternal and neonatal morbidity which is why no treatment is warranted.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Kamaran Shorsh | 24/09
2 kommentarer
af Julius Vindbjerg Nissen | 24/09
4 kommentarer
af Carsten Anker Edmund | 24/09
26 kommentarer
af Helle Lone Jensen | 23/09
1 Kommentar
af Martin Gottliebsen | 21/09
2 kommentarer
af Bente Ulla Rasmusson | 20/09
1 Kommentar
af Carsten Reidies Bjarkam | 18/09
1 Kommentar